Literature DB >> 25979541

Stereotactic radiation therapy combined with immunotherapy: augmenting the role of radiation in local and systemic treatment.

Andrew B Sharabi, Phuoc T Tran, Michael Lim, Charles G Drake, Theodore L Deweese.   

Abstract

Stereotactic radiosurgery and stereotactic body radiation therapy are two contemporary radiation modalities that can treat tumors in any area of the body using highly focused radiation. Recently, immunotherapy has established itself as a viable and powerful anticancer treatment. In this review we detail the rationale supporting a combination of immunotherapy and stereotactic radiation. Additionally, we discuss the evidence for the immune stimulatory effects of focused radiation and the role that radiation may play in enhancing the systemic treatment effects of immunotherapy.

Entities:  

Mesh:

Year:  2015        PMID: 25979541      PMCID: PMC4814161     

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  77 in total

1.  Radiosurgery followed by planned observation in patients with one to three brain metastases.

Authors:  Johannes Lutterbach; Donatus Cyron; Karl Henne; Christoph B Ostertag
Journal:  Neurosurgery       Date:  2003-05       Impact factor: 4.654

2.  Rapid induction of cytokine gene expression in the lung after single and fractionated doses of radiation.

Authors:  J H Hong; C S Chiang; C Y Tsao; P Y Lin; W H McBride; C J Wu
Journal:  Int J Radiat Biol       Date:  1999-11       Impact factor: 2.694

3.  Up-regulation of the pro-inflammatory chemokine CXCL16 is a common response of tumor cells to ionizing radiation.

Authors:  Satoko Matsumura; Sandra Demaria
Journal:  Radiat Res       Date:  2010-04       Impact factor: 2.841

Review 4.  HMGB1 as a DNA-binding cytokine.

Authors:  Ulf Andersson; Helena Erlandsson-Harris; Huan Yang; Kevin J Tracey
Journal:  J Leukoc Biol       Date:  2002-12       Impact factor: 4.962

Review 5.  Immune checkpoint modulation: rational design of combination strategies.

Authors:  Dmitriy Zamarin; Michael A Postow
Journal:  Pharmacol Ther       Date:  2015-01-10       Impact factor: 12.310

Review 6.  Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice.

Authors:  Robert D Timmerman; Joseph Herman; L Chinsoo Cho
Journal:  J Clin Oncol       Date:  2014-08-11       Impact factor: 44.544

7.  Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study.

Authors:  S F Slovin; C S Higano; O Hamid; S Tejwani; A Harzstark; J J Alumkal; H I Scher; K Chin; P Gagnier; M B McHenry; T M Beer
Journal:  Ann Oncol       Date:  2013-03-27       Impact factor: 32.976

8.  HMGB1 is an endogenous immune adjuvant released by necrotic cells.

Authors:  Patrizia Rovere-Querini; Annalisa Capobianco; Paola Scaffidi; Barbara Valentinis; Federica Catalanotti; Marta Giazzon; Ingrid E Dumitriu; Susanne Müller; Matteo Iannacone; Catia Traversari; Marco E Bianchi; Angelo A Manfredi
Journal:  EMBO Rep       Date:  2004-07-23       Impact factor: 8.807

9.  Nivolumab plus ipilimumab in advanced melanoma.

Authors:  Jedd D Wolchok; Harriet Kluger; Margaret K Callahan; Michael A Postow; Naiyer A Rizvi; Alexander M Lesokhin; Neil H Segal; Charlotte E Ariyan; Ruth-Ann Gordon; Kathleen Reed; Matthew M Burke; Anne Caldwell; Stephanie A Kronenberg; Blessing U Agunwamba; Xiaoling Zhang; Israel Lowy; Hector David Inzunza; William Feely; Christine E Horak; Quan Hong; Alan J Korman; Jon M Wigginton; Ashok Gupta; Mario Sznol
Journal:  N Engl J Med       Date:  2013-06-02       Impact factor: 91.245

10.  Immune responses following stereotactic body radiotherapy for stage I primary lung cancer.

Authors:  Yoshiyasu Maehata; Hiroshi Onishi; Kengo Kuriyama; Shinichi Aoki; Masayuki Araya; Ryo Saito; Licht Tominaga; Mitsuhiko Oguri; Tsutomu Araki
Journal:  Biomed Res Int       Date:  2013-11-10       Impact factor: 3.411

View more
  31 in total

Review 1.  Radiotherapy and immunotherapy: a beneficial liaison?

Authors:  Ralph R Weichselbaum; Hua Liang; Liufu Deng; Yang-Xin Fu
Journal:  Nat Rev Clin Oncol       Date:  2017-01-17       Impact factor: 66.675

Review 2.  Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance.

Authors:  C Alberti
Journal:  G Chir       Date:  2017 Sep-Oct

3.  Quality Assessment of Stereotactic Radiosurgery of a Melanoma Brain Metastases Model Using a Mouselike Phantom and the Small Animal Radiation Research Platform.

Authors:  Cheng-Chia Wu; Kunal R Chaudhary; Yong Hum Na; David Welch; Paul J Black; Adam M Sonabend; Peter Canoll; Yvonne M Saenger; Tony J C Wang; Cheng-Shie Wuu; Tom K Hei; Simon K Cheng
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-05-19       Impact factor: 7.038

Review 4.  Immunomodulatory effects of radiation: what is next for cancer therapy?

Authors:  Anita Kumari; Samantha S Simon; Tomika D Moody; Charlie Garnett-Benson
Journal:  Future Oncol       Date:  2015-12-01       Impact factor: 3.404

Review 5.  Therapeutic cancer vaccines.

Authors:  Mansi Saxena; Sjoerd H van der Burg; Cornelis J M Melief; Nina Bhardwaj
Journal:  Nat Rev Cancer       Date:  2021-04-27       Impact factor: 60.716

6.  Tumor-targeted IL-12 combined with local irradiation leads to systemic tumor control via abscopal effects in vivo.

Authors:  Franziska Eckert; Ivan Jelas; Moritz Oehme; Stephan M Huber; Katja Sonntag; Christian Welker; Stephen D Gillies; Wolfgang Strittmatter; Daniel Zips; Rupert Handgretinger; Karin Schilbach
Journal:  Oncoimmunology       Date:  2017-04-28       Impact factor: 8.110

Review 7.  The Current and Evolving Role of Radiation Therapy for Central Nervous System Metastases from Breast Cancer.

Authors:  Shyam Tanguturi; Laura E G Warren
Journal:  Curr Oncol Rep       Date:  2019-04-16       Impact factor: 5.075

8.  The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases.

Authors:  Paul W Sperduto; Wen Jiang; Paul D Brown; Steve Braunstein; Penny Sneed; Daniel A Wattson; Helen A Shih; Ananta Bangdiwala; Ryan Shanley; Natalie A Lockney; Kathryn Beal; Emil Lou; Thomas Amatruda; William A Sperduto; John P Kirkpatrick; Norman Yeh; Laurie E Gaspar; Jason K Molitoris; Laura Masucci; David Roberge; James Yu; Veronica Chiang; Minesh Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-03-29       Impact factor: 7.038

Review 9.  PACIFIC: shifting tides in the treatment of locally advanced non-small cell lung cancer.

Authors:  Andrew Bang; Jonathan D Schoenfeld; Alexander Y Sun
Journal:  Transl Lung Cancer Res       Date:  2019-09

10.  Acute neurologic toxicity of palliative radiotherapy for brain metastases in patients receiving immune checkpoint blockade.

Authors:  W Tristram Arscott; Simeng Zhu; John P Plastaras; Amit Maity; Michelle Alonso-Basanta; Joshua Jones
Journal:  Neurooncol Pract       Date:  2018-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.